Results 111 to 120 of about 703 (170)

Inhibitory effect of Endostar on HIF-1 with upregulation of MHC-I in lung cancer cells. [PDF]

Cancer Biol Ther
Zhao MZ, Zheng HF, Wang JN, Zhang YM, Wang HJ, Zhao ZW.   +5 more
europepmc   +1 more source

Endostatin derivative angiogenesis inhibitors.

Chinese medical journal, 2010
To throw light on the superiority of the anti-angiogenesis activity of endostatin (ES) derivatives by reviewing the recent progress in the field of ES molecular structure modification.The data used in this article were mainly from PubMed with relevant English articles published from 1971 to May 2008. The search terms were "endostatin" and "angiothesis".
openaire   +1 more source

A single-center, retrospective study-spring-evaluating the efficacy and safety of recombinant human vascular endothelial inhibitor combined with anti-PD-1 in elderly patients aged 80 and above with NSCLC. [PDF]

Front Immunol
Xing T, Gao Q, Zhu H, Gao J, Yan G.
europepmc   +1 more source

Recent Trends in Medical Management of Endometriosis. [PDF]

J Obstet Gynaecol India
Patel M.
europepmc   +1 more source

Endostatin turns heads [PDF]

Nature Medicine, 2002
openaire   +1 more source

Endostatin-expressing endometrial mesenchymal stem cells inhibit angiogenesis in endometriosis through the miRNA-21-5p/TIMP3/PI3K/Akt/mTOR pathway. [PDF]

Stem Cells Transl Med
Cheng Y, Guo Q, Cheng Y, Wang D, Sun L, Liang T, Wang J, Wu H, Peng Z, Zhang G.   +9 more
europepmc   +1 more source

Endostatin as a biomarker of systemic sclerosis: insights from a systematic review and meta-analysis. [PDF]

Front Immunol
Mangoni AA, Zinellu A.
europepmc   +1 more source

Real-world effectiveness and safety of recombinant human endostatin plus PD-1 inhibitors and chemotherapy as first-line treatment for EGFR/ALK-negative, advanced or metastatic non-small cell lung cancer. [PDF]

BMC Cancer
Zhang J, Lv PY, Zhao X, Liu ML, Qiu LP, Yang ZZ, Sun SJ, Zhang GQ.   +7 more
europepmc   +1 more source

Immunotherapy combined with antiangiogenic therapy as third- or further-line therapy for stage IV non-small cell lung cancer patients with ECOG performance status 2: A retrospective study. [PDF]

Cancer Med
Li S, Yu ZS, Liu HZ, Li SJ, Wang MY, Ning FL, Tian LJ.   +6 more
europepmc   +1 more source

Effects of concurrent chemoradiotherapy with or without Endostar on the regression of retropharyngeal lymph node and prognosis of patients with locally advanced nasopharyngeal carcinoma: a retrospective study. [PDF]

J Cancer Res Clin Oncol
Song JM, Mo N, Lv YQ, Huang LL, Wen YJ, Liu T, Li ZR, Wang RS, Zhang TT.   +8 more
europepmc   +1 more source